The pharmaceutical industry is aggressively evolving, with growing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key copyrightple of this trend. To address this demand, US-based manufacturing services are stepping forward. These companies offer a comprehensive suite of services, from